Although overall cancer mortality rates are declining for Black patients, they continue to have higher mortality rates than White patients for some cancers.
Zydus Lifesciences Ltd has received USFDA approval to manufacture a generic version of Apalutamide tablets for prostate cancer treatment. The 60 mg tablets will be produced in Ahmedabad, addressing a ...
The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 mg. Shares of Zydus Lifesciences Ltd ended at ₹901.15, up by ₹7.85, or 0.88% ...
Prostate Cancer UK's Big Golf Race. Prostate Cancer UK is calling on golfers across the UK to help fund life-saving projects.
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent.
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 million Transaction expected to close by mid-2025 Upon close of sale of FibroGen China, cash runway exte ...
11h
Vietnam Investment Review on MSNIlluccix® Approved for Prostate Cancer Imaging in Brazil First Marketing Authorization in Latin AmericaMELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...
Free prostate cancer screenings will be available at the Pike County Health Department at 900 S. Franklin Drive from 10 a.m. until 2 p.m. on March 22. Prostate Cancer is the second leading cause of ...
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...
Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.
Saikali S, Khosravi P, Gamal A, et al. MP07-02 Detection of Prostate Cancer Extracapsular Extension with MRI Using Deep Learning Methods. J Urol. 2024 May;211 (5S):e105.
Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results